… as EQT Life Sciences, Fidelity, Pfizer, and Sanofi. AgomAb’s approach … and the broader IPO landscape AgomAb’s IPO filing comes at … the company intends to use IPO proceeds to advance ontunisertib into … Eikon Therapeutics filed for an IPO earlier this month. It …

Some companies are making use of the world's newest private jet, a luxurious Gulfstream that costs over $70 million. Three Gulfstream G800 jets have landed near Davos today, flight-tracking data shows. Some companies are making use of the world's …

… filing for a U.S. initial public offering on Friday, as the pre … for new listings. The IPO market is expected to strengthen … developers to test public markets. Pfizer invested in Agomab as part … significant shareholders ahead of its IPO. The company has raised …

… #39;s Hong Kong IPO late last year attracted pharmaceutical … discovery Fresh from a colossal IPO, AI-assisted pharmacology pioneer  … subscription rate among the healthcare IPOs last year that met … Novo Nordisk, Boehringer Ingelheim and Pfizer. By the middle of …

… oral obesity medications. And Pfizer CEO Albert Bourla noted how … Lilly.” — Jonathan Gardner Renewed IPO optimism  Less than a dozen … , Metsera, was acquired by Pfizer. IPOs, then, could rebound in the … though there could be IPO opportunities for a handful of …

… not confirming or commenting on IPO plans, I spoke to CEO … like that.”  As a potential IPO comes into view, Martin told … , raised $61 million in funding. Pfizer Ventures and Apricot Capital led … . Financial terms were not disclosed. IPOS - BitGo, Sioux Falls, S …

… 2025 that saw limited biotech IPO activity, Aktis found sufficient … Aktis technology platform. In the IPO filing, Aktis says its … conjugate (ADC) marketed by Pfizer and Astellas Pharma for urothelial … 2 million. Combined with the IPO proceeds, Aktis said it …

… $318 million from an initial public offering, the first for a … the same protein that Pfizer’s bladder cancer drug Padcev … radiopharmaceutical targets. Prior to its IPO, Aktis banked $346 million … than a dozen firms pricing IPOs, according to BioPharma Dive …

… ;entering a more discerning IPO marketplace where drug innovators with … said. Still, he continued, IPOs will remain a crucial part … , days before announcing its IPO, injectable MET-097 again … companies, including lawsuits from Pfizer, a provocation by Novo …

… company to file for an initial public offering in several weeks, outlining … private financing before submitting its IPO paperwork. Dive Insight: … year to forget for biotech IPOs. Already in the throes … bladder cancer drug owned by Pfizer. The company noted how, …